Tag:
ISTA Pharmaceuticls
Latest Headlines
Latest Headlines
ISTA one for two in a pair of Phase III eye drug studies
ISTA Pharmaceuticals says it snagged the late-stage data it needs to win an approval for Prolensa, which relies on a low concentration of bromfenac to treat pain and inflammation caused by cataract
FDA hands Ista an approval for itchy-eye treatment
Ista Pharmaceuticals has won FDA approval for its new treatment for itchy eyes, an event that spurred the developer to move up plans to expand its sales force and launch the therapy in the fourth
